Menu

Merck & Co., Inc. MRK

Full chart Compare
Set alert

Price alert · MRK

All alert types
146.95 USD -0.23 (-0.16%)

At closeNov 12, 2026, 6:56 PM EST

146.70 -0.25 -0.17%

After hours · Nov 12, 6:56 PM ET

146.86 Day range 149.31
91.45 52-week range 156.45
YTD
+39.61%
1 year
+60.69%

Discussion (164)

Sign in to join the discussion

frank fager MRK 1 year ago #32

AIDS cure cancer cure will blow up this

"The global HIV drugs market was valued at $34.13 billion in 2023, and is projected to grow to $58.24 billion by 2032."

35 billion in Keytruda sales

There maybe some resistance from the big pharma world to stop ImmunityBio from curing "yes curing" diseases and cancer not treating them!

HIV drugs plus Keytruda 70-100 billion in lost sales!

Anktiva and BioShield could wipe out 100-200 billion in revenues!

https://youtu.be/nosIYa3Ulr0

frank fager MRK 1 year ago #33

IBRX

https://immunitybio.com/

Up .10 is up $30,000 when you have 300,000 shares

A move from 2.90 to 6.90 I will be up 1.2 m 
When we hit 100 I will be up 30 million :)

Moderna MRNA the seller of mRNA poison jabs went to $380 why wouldn't the cure for aids and multiple cancers hit $350???IBRX will when the MSM covers the PR and + news about Anktiva and BioShield! Wow that will be $100 million now that's real money not day trading for thousands!

frank fager MRK 1 year ago #34

Keytruda sales are in trouble soon Anktiva from ImmunityBio works when Keytruda is starting to fail! Move over MRK IBRX is moving soon!

frank fager MRK 1 year ago #39

Joyb

Exactly Anktiva and BioShield work when Ketruda fails! Ketruda is finished soon!

frank fager MRK 1 year ago #40

I have never owned MRK

https://youtu.be/fNVHyYNInXc

Watch that and tell me Covid, the plandemic, wasn't planned and mRNA wasn't predetermined to be the jab of choice! Plandemic created motivation to skip the normal review authorization processes and why was that necessary? Because it would take years and would have fully exposed the risks for mRNA jabs!!!!